Abstract: An under-the-cabinet household opening appliance including an electric can opener, a jar opener mounted on the bottom wall of the can opener housing, and a sheath for a scissors on the back of the housing. A scissors holder in the sheath releasably retains a scissors within the sheath. A bottle opener and a hone are also mounted on the appliance housing.
Abstract: An apparatus and method for signal transmission with isolation in medical devices. Data signals, such as patient measurement data and medical instrumentation control signals are converted to dynamic signals which are transmitted on power lines through an isolation module, such as a transformer. The dynamic signals are then converted to data signals having a voltage based on the frequency of the dynamic signals.
Type:
Grant
Filed:
August 1, 2007
Date of Patent:
November 23, 2010
Assignee:
Siemens Medical Solutions USA, Inc.
Inventors:
Detlef W. Koertge, Hongxuan Zhang, Bryon Pelzek
Abstract: Certain exemplary embodiments provide a system for providing help information supporting at least one executable application. The system can comprise an interface processor for receiving user-entered data representing a help message conveying help information, a creation time indicator identifying a creation time of the help message, and an identifier for identifying a help information repository associated with the help message. A data processor can store the help message in the help information repository in order of creation by using the creation time indicator.
Abstract: A speech converter in a speech processing system modifies various aspects of input speech. The speech converter receives a formants signal representing an input speech signal. The speech converter may also receive a formant scaling command or a user selection of one of multiple control signals, each specifying a manner of modifying one or more of the received signals (i.e., formants, voicing, pitch, gain). The speech converter modifies at least one of the formants, voicing, pitch, and/or gain signals as specified by the selected voice font.
Type:
Grant
Filed:
April 4, 2006
Date of Patent:
November 9, 2010
Assignee:
QUALCOMM Incorporated
Inventors:
Daniel J. Sinder, Ananthapadmanabhan Aasanipalai Kandhadai
Abstract: The invention provides compounds of formula I or a pharmaceutically acceptable salt or ester thereof wherein the symbols have meaning as defined, which are inhibitors of cathepsin K and find use pharmaceutically for treatment of diseases and medical conditions in which cathepsin K is implicated, e.g. various disorders including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors.
Type:
Grant
Filed:
March 6, 2009
Date of Patent:
October 26, 2010
Assignee:
Novartis AG
Inventors:
Eva Altmann, Claudia Betschart, Kenji Hayakawa, Osamu Irie, Junichi Sakaki, Genji Iwasaki, Rene Lattmann, Martin Missbach, Naoki Teno
Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially lymphoma carcinomas. In addition, the present invention describes the use of novel compositions for use in screening methods.
Abstract: A method for layering lenses includes: plasma treating a lens surface; applying a removable ink layer onto the lens surface; applying at least one base ink layer over the removable ink layer; applying at least one colored ink layer over the base ink layer; and removing the removable ink layer. Additional steps may include drying the lens, sealing the sides of the lens, and applying liquid to the lens before removing the removable ink layer.
Abstract: The present invention provides a compound of the Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly frailty, osteoporosis, osteopenia, and male and female sexual dysfunction comprising administering to a patient in need thereof an effective amount of a compound of Formula (I).
Type:
Grant
Filed:
May 10, 2006
Date of Patent:
October 5, 2010
Assignee:
Eli Lilly and Company
Inventors:
Konstantinos Gavardinas, Prabhakar Kondaji Jadhav, Douglas Richard Stack
Abstract: The present invention provides a compound of the formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart disease, hypertension, rheumatoid arthritis or inflammation, comprising administering to a patient in thereof an effective amount of a compound of Formula (I).
Type:
Grant
Filed:
December 8, 2004
Date of Patent:
September 28, 2010
Assignee:
Eli Lilly and Company
Inventors:
Konstantinos Gavardinas, Jonathan Edward Green, Prabhakar Kondaji Jadhav, Donald Paul Matthews
Abstract: Automatic weight adjustment (AWA) to derive an optimal color correction matrix may address unbalanced color reproduction performance among different illuminations and/or unbalanced color reproduction performance for specific memory colors. AWA may emphasize particular colors and equalize color performance. AWA may be implemented in an automatic process with optional manual operation.
Type:
Grant
Filed:
April 27, 2006
Date of Patent:
September 21, 2010
Assignee:
QUALCOMM Incorporated
Inventors:
Shuxue Quan, Chinchuan Andrew Chiu, Xiaoyun Jiang
Abstract: The present invention relates 3,4-dihydro-benzo[e][1,3]oxazin-2-ones which are substituted at the nitrogen atom by unsubstituted or substituted (C1-8)alkyl, (C3-8)cycloalkyl, (C3-8)cycloalkyl(C1-4)alkyl, (C6-18)aryl or (C6-18)aryl(C1-4)alkyl and their use as pharmaceuticals.
Type:
Grant
Filed:
April 13, 2006
Date of Patent:
September 14, 2010
Assignee:
Novartis AG
Inventors:
Andreas Billich, Hubert Gstach, Philipp Lehr
Abstract: N-(benzenesulphonyl)-2,3-dihydro-1H-indols, wherein the indol is substituted by cyano, carboxy or alkylcarbonyloxy and their use as therapeutical agents.
Type:
Grant
Filed:
December 22, 2006
Date of Patent:
August 24, 2010
Assignee:
Novartis AG
Inventors:
Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
Abstract: Method of making eyeglass lens are disclosed where the lens are made of layers which include an outer, convex hard coating, a layer of hard epoxy, a PVA film wherein the color is dipped in water without color dye, a layer of soft epoxy, a base material, and an inner, concave hard coating. Other methods configuration of lens also include a camouflaged patterned lens, a layer of hard epoxy, a polyurethane mixture, a PVA film wherein the color is dipped in water without color dye, a layer of soft epoxy, a base material, and an inner, concave hard coating.
Abstract: The present invention relates to a disposable absorbent article, e.g. a diaper, having a backsheet, an absorbent core and a topsheet, said absorbent article having a length L, said topsheet having an opening and primary elasticated areas and secondary elasticated areas, the latter being curved or angled, having an overall curvature with a radius of from 0.3 L to 3.2 L, wherein the average transverse distance between a primary elasticated area and a secondary elasticated area of a crotch side portion is preferably at least 15 mm.
Type:
Grant
Filed:
August 20, 2007
Date of Patent:
August 10, 2010
Assignee:
The Procter & Gamble Company
Inventors:
Joerg Mueller, Cornelia Martynus, Anja Hoffmann, Mattias Schmidt, John Costello, Ann Sullivan, Gregg Flender
Abstract: A disposable absorbent article including a chassis and an absorbent assembly. The chassis is folded laterally inward and outward in a zigzag pattern to form laterally opposing layered containment pockets and laterally opposing side flaps interiorly of the layered containment pockets. Each side flap has a longitudinally extending elastic gathering member attached adjacent to its distal edge. The absorbent assembly includes an absorbent core that may contain superabsorbent particles, which may be contained inside pockets.
Abstract: Compounds of formula I, wherein one of R1 and R2 is thienyl which is substituted by halogen and the other of R1 and R2 is substituted phenyl, wherein the substituents are as defined in the claims, with the proviso that the phenyl group is substituted by at least a cyano, carboxy or (C1-4)alkyloxycarbonyl group, are inhibitors of CCR9 activity and useful for therapeutic treatment.
Type:
Grant
Filed:
December 22, 2006
Date of Patent:
July 20, 2010
Assignee:
Novartis AG
Inventors:
Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski